
Vaxxas receives $6.4M to advance needle-free mRNA vaccines
The Coalition for Epidemic Preparedness Innovations (CEPI) will fund Australian medtech manufacturer Vaxxas to advance the development of its high-density microarray patch for mRNA vaccines.
Read More